+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Regulatory Affairs Market Size, Share & Trends Analysis Report By Categories (Drugs, Biologics), By Company Size (Small, Large), By Type, By Services, By Product Stage, By Indication, By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • August 2024
  • Region: Global
  • Grand View Research
  • ID: 5415548
Description Jump to:

Regulatory Affairs Market Growth & Trends

The global regulatory affairs market size is expected to reach USD 26.0 billion by 2030, expanding at a CAGR of 8.2% from 2024 to 2030. The factors expected to contribute to the growth of this market include changing regulatory requirements based on business activities and geographies, an increase in clinical trials & drug approvals along with accelerated regulatory approval, and technological advancement in regulatory software. Also, the evolution of personalized medicines, the increasing need for companies to focus on core business activities, and economic and competitive pressures are other factors that are contributing to the growth of the market.

The pharmaceutical and regulatory agencies joined forces to rapidly develop vaccines and medical products required to fight against the COVID-19 infection. The regulatory authorities take numerous precautions to ensure patient and personnel safety during a clinical trial, as well as data integrity and good laboratory practices are maintained. Growth in markets for biosimilars, orphan drugs, personalized medicines, companion diagnostics, and adaptive trial designs is projected to boost the demand for regulatory specialization in these areas. As companies venture into newer fields, the growing need to comply with regulations is boosting the demand for specialized service providers with expertise in regulatory affairs. Patent expiration of biologics, such as Simulect, Vectibix, Mircera, and Kineret, is increasing the demand and development of biosimilars, thereby contributing to the demand for regulatory services.

Several companies are actively involved in collaborations and new product development to gain leadership in the personalized medicine market, indicating a need for supportive regulatory affairs. For instance, in May 2020, Regeneron Pharmaceuticals, Inc. collaborated with Colorado Center for Personalized Medicine to design advancements in personalized medicine and human genetics.

Regulatory Affairs Market Report Highlights

  • The outsourcing segment dominated the market with a share of 58.16% in 2023. The segment's growth is mainly due to the growing focus of pharmaceutical and medical device companies on outsourcing their activities, which allows them to access specialized expertise and resources they may not have in-house.
  • The regulatory writing & publishing segment dominated the market, accounting for 36.41% of the global revenue in 2023.
  • The medical devices segment dominated the market with a share of 41.05% in 2023. The segment's growth can be attributed to factors such as constant technological advancements and the increasing focus of market players on outsourcing medical device activities so they can focus more on their core competencies.
  • The oncology segment dominated the market with a share of 32.77% in 2023. The growth of the segment is mainly due to the increasing prevalence of cancer, which requires effective and safe treatment options.
  • Asia Pacific dominated the market and accounted for a 37.82% share in 2023. The growth in the region is attributed to factors such as an enhanced regulatory landscape, an increasing number of clinical trials, a growing number of pharmaceutical companies, and the availability of skilled workers in the region.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Services Segment
1.2.3. Category Segment
1.2.4. Indication Segment
1.2.5. Product Stage Segment
1.2.6. Company Size Segment
1.2.7. Indication Segment
1.2.8. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Regulatory Affairs Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Changing Regulatory Landscape
3.2.1.2. Entry Of Companies into The Global Market
3.2.1.3. Life Science Companies Focusing on Their Core Competencies
3.2.1.4. Economic And Competitive Pressures
3.2.1.5. Demand For the Faster Approval Process for Breakthrough Drugs and Devices
3.2.1.6. Growth In Emerging Areas Such as Personalized Medicine, Biosimilars, And Orphan Drugs
3.2.2. Market Restraint Analysis
3.2.2.1. Risk Associated with Data Security
3.2.2.2. Monitoring Issues and Lack of Standardization
3.3. Regulatory Affairs Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Regulatory Affairs Market: Services Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Regulatory Affairs Market Services Movement Analysis
4.3. Global Regulatory Affairs Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Billion)
4.4. Regulatory Consulting
4.4.1. Regulatory consulting market estimates and forecasts, 2018 - 2030 (USD Billion)
4.5. Legal Representation
4.5.1. Legal representation market estimates and forecasts, 2018 - 2030 (USD Billion)
4.6. Regulatory Writing & Publishing
4.6.1. Regulatory writing & publishing market estimates and forecasts, 2018 - 2030 (USD Billion)
4.6.2. Writing
4.6.2.1. Writing market estimates and forecasts, 2018 - 2030 (USD Billion)
4.6.3. Publishing
4.6.3.1. Publishing market estimates and forecasts, 2018 - 2030 (USD Billion)
4.7. Product Registration & Clinical Trial Applications
4.7.1. Product registration & clinical trial applications market estimates and forecasts, 2018 - 2030 (USD Billion)
4.8. Other Services
4.8.1. Other services market estimates and forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Regulatory Affairs Market: Category Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Regulatory Affairs Market Category Movement Analysis
5.3. Global Regulatory Affairs Market Size & Trend Analysis, by Category, 2018 to 2030 (USD Billion)
5.4. Drugs
5.4.1. Drugs market estimates and forecasts, 2018 - 2030 (USD Billion)
5.4.2. Innovator
5.4.2.1. Innovator market estimates and forecasts, 2018 - 2030 (USD Billion)
5.4.2.2. Preclinical
5.4.2.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.4.2.3. Clinical
5.4.2.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.4.2.4. Pre-Market Approval (PMA)
5.4.2.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Billion)
5.4.3. Generics
5.4.3.1. Generics market estimates and forecasts, 2018 - 2030 (USD Billion)
5.4.3.2. Preclinical
5.4.3.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.4.3.3. Clinical
5.4.3.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.4.3.4. Pre-Market Approval (PMA)
5.4.3.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5. Biologics
5.5.1. Biologics market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.2. Biotech
5.5.2.1. Biotech market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.2.2. Preclinical
5.5.2.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.2.3. Clinical
5.5.2.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.2.4. Pre-Market Approval (PMA)
5.5.2.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.3. ATMP
5.5.3.1. ATMP market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.3.2. Preclinical
5.5.3.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.3.3. Clinical
5.5.3.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.3.4. Pre-Market Approval (PMA)
5.5.3.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.4. Biosimilars
5.5.4.1. Biosimilars market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.4.2. Preclinical
5.5.4.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.4.3. Clinical
5.5.4.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.5.4.4. Pre-Market Approval (PMA)
5.5.4.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Billion)
5.6. Medical Devices
5.6.1. Medical devices market estimates and forecasts, 2018 - 2030 (USD Billion)
5.6.2. Diagnostics
5.6.2.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
5.6.2.2. Preclinical
5.6.2.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.6.2.3. Clinical
5.6.2.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.6.2.4. Pre-Market Approval (PMA)
5.6.2.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Billion)
5.6.3. Therapeutics
5.6.3.1. Therapeutics market estimates and forecasts, 2018 - 2030 (USD Billion)
5.6.3.2. Preclinical
5.6.3.2.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.6.3.3. Clinical
5.6.3.3.1. Clinical market estimates and forecasts, 2018 - 2030 (USD Billion)
5.6.3.4. Pre-Market Approval (PMA)
5.6.3.4.1. Pre-Market Approval (PMA) market estimates and forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Regulatory Affairs Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Regulatory Affairs Market Indication Movement Analysis
6.3. Global Regulatory Affairs Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Billion)
6.4. Oncology
6.4.1. Oncology market estimates and forecasts, 2018 - 2030 (USD Billion)
6.5. Neurology
6.5.1. Neurology market estimates and forecasts, 2018 - 2030 (USD Billion)
6.6. Cardiology
6.6.1. Cardiology market estimates and forecasts, 2018 - 2030 (USD Billion)
6.7. Immunology
6.7.1. Immunology market estimates and forecasts, 2018 - 2030 (USD Billion)
6.8. Others
6.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Regulatory Affairs Market: Product Stage Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Regulatory Affairs Market Product Stage Movement Analysis
7.3. Global Regulatory Affairs Market Size & Trend Analysis, by Product Stage, 2018 to 2030 (USD Billion)
7.4. Preclinical
7.4.1. Preclinical market estimates and forecasts, 2018 - 2030 (USD Billion)
7.5. Clinical studies
7.5.1. Clinical studies market estimates and forecasts, 2018 - 2030 (USD Billion)
7.6. PMA
7.6.1. PMA market estimates and forecasts, 2018 - 2030 (USD Billion)
Chapter 8. Regulatory Affairs Market: Type Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Regulatory Affairs Market Type Movement Analysis
8.3. Global Regulatory Affairs Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Billion)
8.4. In-house
8.4.1. In-house market estimates and forecasts, 2018 - 2030 (USD Billion)
8.5. Outsourced
8.5.1. Outsourced market estimates and forecasts, 2018 - 2030 (USD Billion)
Chapter 9. Regulatory Affairs Market: Company Size Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Global Regulatory Affairs Market Company Size Movement Analysis
9.3. Global Regulatory Affairs Market Size & Trend Analysis, by Company Size, 2018 to 2030 (USD Billion)
9.4. Small
9.4.1. Small market estimates and forecasts, 2018 - 2030 (USD Billion)
9.5. Medium
9.5.1. Medium market estimates and forecasts, 2018 - 2030 (USD Billion)
9.6. Large
9.6.1. Large market estimates and forecasts, 2018 - 2030 (USD Billion)
Chapter 10. Regulatory Affairs Market: End Use Estimates & Trend Analysis
10.1. Segment Dashboard
10.2. Global Regulatory Affairs Market End Use Movement Analysis
10.3. Global Regulatory Affairs Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Billion)
10.4. Medical Device Companies
10.4.1. Medical device companies market estimates and forecasts, 2018 - 2030 (USD Billion)
10.5. Pharmaceutical Companies
10.5.1. Pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Billion)
10.6. Biotechnology Companies
10.6.1. Biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Billion)
Chapter 11. Regulatory Affairs Market: Regional Estimates & Trend Analysis
11.1. Regional Market Share Analysis, 2023 & 2030
11.2. Regional Market Dashboard
11.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
11.4. North America
11.4.1. North America Market Estimates and Forecasts 2018 - 2030 (USD Billion)
11.4.2. U.S.
11.4.2.1. Key country dynamics
11.4.2.2. Competitive scenario
11.4.2.3. U.S. market estimates and forecasts 2018 - 2030 (USD Billion)
11.4.3. Canada
11.4.3.1. Key country dynamics
11.4.3.2. Competitive scenario
11.4.3.3. Canada market estimates and forecasts 2018 - 2030 (USD Billion)
11.4.4. Mexico
11.4.4.1. Key country dynamics
11.4.4.2. Competitive scenario
11.4.4.3. Mexico market estimates and forecasts 2018 - 2030 (USD Billion)
11.5. Europe
11.5.1. Europe Market Estimates and Forecasts 2018 - 2030 (USD Billion)
11.5.2. UK
11.5.2.1. Key country dynamics
11.5.2.2. Competitive scenario
11.5.2.3. UK market estimates and forecasts 2018 - 2030 (USD Billion)
11.5.3. Germany
11.5.3.1. Key country dynamics
11.5.3.2. Competitive scenario
11.5.3.3. Germany market estimates and forecasts 2018 - 2030 (USD Billion)
11.5.4. France
11.5.4.1. Key country dynamics
11.5.4.2. Competitive scenario
11.5.4.3. France market estimates and forecasts 2018 - 2030 (USD Billion)
11.5.5. Italy
11.5.5.1. Key country dynamics
11.5.5.2. Competitive scenario
11.5.5.3. Italy market estimates and forecasts 2018 - 2030 (USD Billion)
11.5.6. Spain
11.5.6.1. Key country dynamics
11.5.6.2. Competitive scenario
11.5.6.3. Spain market estimates and forecasts 2018 - 2030 (USD Billion)
11.5.7. Denmark
11.5.7.1. Key country dynamics
11.5.7.2. Competitive scenario
11.5.7.3. Denmark market estimates and forecasts 2018 - 2030 (USD Billion)
11.5.8. Norway
11.5.8.1. Key country dynamics
11.5.8.2. Competitive scenario
11.5.8.3. Norway market estimates and forecasts 2018 - 2030 (USD Billion)
11.5.9. Netherlands
11.5.9.1. Key country dynamics
11.5.9.2. Competitive scenario
11.5.9.3. Netherlands market estimates and forecasts 2018 - 2030 (USD Billion)
11.5.10. Switzerland
11.5.10.1. Key country dynamics
11.5.10.2. Competitive scenario
11.5.10.3. Switzerland market estimates and forecasts 2018 - 2030 (USD Billion)
11.5.11. Sweden
11.5.11.1. Key country dynamics
11.5.11.2. Competitive scenario
11.5.11.3. Sweden market estimates and forecasts 2018 - 2030 (USD Billion)
11.6. Asia Pacific
11.6.1. Asia Pacific Market Estimates and Forecasts 2018 - 2030 (USD Billion)
11.6.2. Japan
11.6.2.1. Key country dynamics
11.6.2.2. Competitive scenario
11.6.2.3. Japan market estimates and forecasts 2018 - 2030 (USD Billion)
11.6.3. China
11.6.3.1. Key country dynamics
11.6.3.2. Competitive scenario
11.6.3.3. China market estimates and forecasts 2018 - 2030 (USD Billion)
11.6.4. India
11.6.4.1. Key country dynamics
11.6.4.2. Competitive scenario
11.6.4.3. India market estimates and forecasts 2018 - 2030 (USD Billion)
11.6.5. Australia
11.6.5.1. Key country dynamics
11.6.5.2. Competitive scenario
11.6.5.3. Australia market estimates and forecasts 2018 - 2030 (USD Billion)
11.6.6. South Korea
11.6.6.1. Key country dynamics
11.6.6.2. Competitive scenario
11.6.6.3. South Korea market estimates and forecasts 2018 - 2030 (USD Billion)
11.6.7. Thailand
11.6.7.1. Key country dynamics
11.6.7.2. Competitive scenario
11.6.7.3. Thailand market estimates and forecasts 2018 - 2030 (USD Billion)
11.6.8. Indonesia
11.6.8.1. Key country dynamics
11.6.8.2. Competitive scenario
11.6.8.3. Indonesia market estimates and forecasts 2018 - 2030 (USD Billion)
11.6.9. Malaysia
11.6.9.1. Key country dynamics
11.6.9.2. Competitive scenario
11.6.9.3. Malaysia market estimates and forecasts 2018 - 2030 (USD Billion)
11.6.10. Singapore
11.6.10.1. Key country dynamics
11.6.10.2. Competitive scenario
11.6.10.3. Singapore market estimates and forecasts 2018 - 2030 (USD Billion)
11.6.11. Taiwan
11.6.11.1. Key country dynamics
11.6.11.2. Competitive scenario
11.6.11.3. Taiwan market estimates and forecasts 2018 - 2030 (USD Billion)
11.7. Latin America
11.7.1. Latin America Market Estimates and Forecasts 2018 - 2030 (USD Billion)
11.7.2. Brazil
11.7.2.1. Key country dynamics
11.7.2.2. Competitive scenario
11.7.2.3. Brazil market estimates and forecasts 2018 - 2030 (USD Billion)
11.7.3. Argentina
11.7.3.1. Key country dynamics
11.7.3.2. Competitive scenario
11.7.3.3. Argentina market estimates and forecasts 2018 - 2030 (USD Billion)
11.7.4. Colombia
11.7.4.1. Key country dynamics
11.7.4.2. Competitive scenario
11.7.4.3. Colombia market estimates and forecasts 2018 - 2030 (USD Billion)
11.7.5. Chile
11.7.5.1. Key country dynamics
11.7.5.2. Competitive scenario
11.7.5.3. Chile market estimates and forecasts 2018 - 2030 (USD Billion)
11.8. MEA
11.8.1. MEA Market Estimates and Forecasts 2018 - 2030 (USD Billion)
11.8.2. South Africa
11.8.2.1. Key country dynamics
11.8.2.2. Competitive scenario
11.8.2.3. South Africa market estimates and forecasts 2018 - 2030 (USD Billion)
11.8.3. Saudi Arabia
11.8.3.1. Key country dynamics
11.8.3.2. Competitive scenario
11.8.3.3. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Billion)
11.8.4. UAE
11.8.4.1. Key country dynamics
11.8.4.2. Competitive scenario
11.8.4.3. UAE market estimates and forecasts 2018 - 2030 (USD Billion)
11.8.5. Egypt
11.8.5.1. Key country dynamics
11.8.5.2. Competitive scenario
11.8.5.3. Egypt market estimates and forecasts 2018 - 2030 (USD Billion)
11.8.6. Israel
11.8.6.1. Key country dynamics
11.8.6.2. Competitive scenario
11.8.6.3. Israel market estimates and forecasts 2018 - 2030 (USD Billion)
11.8.7. Kuwait
11.8.7.1. Key country dynamics
11.8.7.2. Competitive scenario
11.8.7.3. Israel market estimates and forecasts 2018 - 2030 (USD Billion)
Chapter 12. Competitive Landscape
12.1. Company/Competition Categorization
12.2. Strategy Mapping
12.3. Company Market Position Analysis, 2023
12.4. Company Profiles/Listing
12.4.1. Accell Clinical Research, LLC
12.4.1.1. Company overview
12.4.1.2. Financial performance
12.4.1.3. Product benchmarking
12.4.1.4. Strategic initiatives
12.4.2. Genpact
12.4.2.1. Company overview
12.4.2.2. Financial performance
12.4.2.3. Product benchmarking
12.4.2.4. Strategic initiatives
12.4.3. Criterium, Inc.
12.4.3.1. Company overview
12.4.3.2. Financial performance
12.4.3.3. Product benchmarking
12.4.3.4. Strategic initiatives
12.4.4. ICON plc
12.4.4.1. Company overview
12.4.4.2. Financial performance
12.4.4.3. Product benchmarking
12.4.4.4. Strategic initiatives
12.4.5. iuvo BioScience, llc.
12.4.5.1. Company overview
12.4.5.2. Financial performance
12.4.5.3. Product benchmarking
12.4.5.4. Strategic initiatives
12.4.6. WuXi AppTec
12.4.6.1. Company overview
12.4.6.2. Financial performance
12.4.6.3. Product benchmarking
12.4.6.4. Strategic initiatives
12.4.7. Medpace
12.4.7.1. Company overview
12.4.7.2. Financial performance
12.4.7.3. Product benchmarking
12.4.7.4. Strategic initiatives
12.4.8. Charles River Laboratories
12.4.8.1. Company overview
12.4.8.2. Financial performance
12.4.8.3. Product benchmarking
12.4.8.4. Strategic initiatives
12.4.9. Laboratory Corporation of America Holdings
12.4.9.1. Company overview
12.4.9.2. Financial performance
12.4.9.3. Product benchmarking
12.4.9.4. Strategic initiatives
12.4.10. Parexel International (MA) Corporation
12.4.10.1. Company overview
12.4.10.2. Financial performance
12.4.10.3. Product benchmarking
12.4.10.4. Strategic initiatives
12.4.11. Freyr
12.4.11.1. Company overview
12.4.11.2. Financial performance
12.4.11.3. Product benchmarking
12.4.11.4. Strategic initiatives
12.4.12. PHARMALEX GMBH
12.4.12.1. Company overview
12.4.12.2. Financial performance
12.4.12.3. Product benchmarking
12.4.12.4. Strategic initiatives
12.4.13. SSI Strategy LLC
12.4.13.1. Company overview
12.4.13.2. Financial performance
12.4.13.3. Product benchmarking
12.4.13.4. Strategic initiatives
12.4.14. Pharmexon
12.4.14.1. Company overview
12.4.14.2. Financial performance
12.4.14.3. Product benchmarking
12.4.14.4. Strategic initiatives
12.4.15. Qvigilance
12.4.15.1. Company overview
12.4.15.2. Financial performance
12.4.15.3. Product benchmarking
12.4.15.4. Strategic initiatives
12.4.16. BlueReg
12.4.16.1. Company overview
12.4.16.2. Financial performance
12.4.16.3. Product benchmarking
12.4.16.4. Strategic initiatives
12.4.17. Cambridge Regulatory Services
12.4.17.1. Company overview
12.4.17.2. Financial performance
12.4.17.3. Product benchmarking
12.4.17.4. Strategic initiatives
12.4.18. VCLS
12.4.18.1. Company overview
12.4.18.2. Financial performance
12.4.18.3. Product benchmarking
12.4.18.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 4 Global Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 5 Global Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 6 Global Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 7 Global Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 8 Global Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 9 Global Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 10 Global Regulatory Affairs, by Region, 2018 - 2030 (USD Billion)
Table 11 North America Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 12 North America Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 13 North America Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 14 North America Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 15 North America Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 16 North America Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 17 North America Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 18 U.S. Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 19 U.S. Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 20 U.S. Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 21 U.S. Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 22 U.S. Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 23 U.S. Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 24 U.S. Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 25 Canada Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 26 Canada Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 27 Canada Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 28 Canada Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 29 Canada Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 30 Canada Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 31 Canada Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 32 Europe Regulatory Affairs, by Country, 2018 - 2030 (USD Billion)
Table 33 Europe Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 34 Europe Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 35 Europe Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 36 Europe Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 37 Europe Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 38 Europe Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 39 Europe Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 40 Germany Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 41 Germany Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 42 Germany Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 43 Germany Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 44 Germany Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 45 Germany Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 46 Germany Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 47 UK Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 48 UK Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 49 UK Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 50 UK Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 51 UK Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 52 UK Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 53 UK Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 54 France Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 55 France Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 56 France Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 57 France Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 58 France Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 59 France Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 60 France Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 61 Italy Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 62 Italy Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 63 Italy Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 64 Italy Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 65 Italy Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 66 Italy Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 67 Italy Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 68 Spain Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 69 Spain Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 70 Spain Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 71 Spain Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 72 Spain Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 73 Spain Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 74 Spain Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 75 Denmark Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 76 Denmark Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 77 Denmark Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 78 Denmark Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 79 Denmark Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 80 Denmark Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 81 Denmark Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 82 Norway Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 83 Norway Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 84 Norway Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 85 Norway Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 86 Norway Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 87 Norway Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 88 Norway Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 89 Netherlands Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 90 Netherlands Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 91 Netherlands Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 92 Netherlands Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 93 Netherlands Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 94 Netherlands Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 95 Netherlands Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 96 Switzerland Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 97 Switzerland Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 98 Switzerland Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 99 Switzerland Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 100 Switzerland Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 101 Switzerland Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 102 Switzerland Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 103 Sweden Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 104 Sweden Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 105 Sweden Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 106 Sweden Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 107 Sweden Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 108 Sweden Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 109 Sweden Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 110 Asia Pacific Regulatory Affairs, by Country, 2018 - 2030 (USD Billion)
Table 111 Asia Pacific Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 112 Asia Pacific Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 113 Asia Pacific Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 114 Asia Pacific Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 115 Asia Pacific Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 116 Asia Pacific Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 117 Asia Pacific Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 118 China Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 119 China Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 120 China Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 121 China Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 122 China Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 123 China Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 124 China Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 125 Japan Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 126 Japan Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 127 Japan Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 128 Japan Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 129 Japan Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 130 Japan Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 131 Japan Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 132 India Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 133 India Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 134 India Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 135 India Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 136 India Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 137 India Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 138 India Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 139 South Korea Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 140 South Korea Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 141 South Korea Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 142 South Korea Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 143 South Korea Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 144 South Korea Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 145 South Korea Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 146 Australia Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 147 Australia Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 148 Australia Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 149 Australia Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 150 Australia Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 151 Australia Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 152 Australia Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 153 Thailand Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 154 Thailand Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 155 Thailand Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 156 Thailand Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 157 Thailand Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 158 Thailand Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 159 Thailand Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 160 Indonesia Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 161 Indonesia Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 162 Indonesia Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 163 Indonesia Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 164 Indonesia Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 165 Indonesia Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 166 Indonesia Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 167 Malaysia Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 168 Malaysia Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 169 Malaysia Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 170 Malaysia Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 171 Malaysia Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 172 Malaysia Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 173 Malaysia Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 174 Singapore Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 175 Singapore Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 176 Singapore Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 177 Singapore Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 178 Singapore Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 179 Singapore Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 180 Singapore Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 181 Taiwan Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 182 Taiwan Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 183 Taiwan Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 184 Taiwan Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 185 Taiwan Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 186 Taiwan Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 187 Taiwan Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 188 Latin America Regulatory Affairs, by Country, 2018 - 2030 (USD Billion)
Table 189 Latin America Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 190 Latin America Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 191 Latin America Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 192 Latin America Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 193 Latin America Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 194 Latin America Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 195 Latin America Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 196 Brazil Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 197 Brazil Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 198 Brazil Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 199 Brazil Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 200 Brazil Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 201 Brazil Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 202 Brazil Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 203 Mexico Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 204 Mexico Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 205 Mexico Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 206 Mexico Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 207 Mexico Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 208 Mexico Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 209 Mexico Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 210 Argentina Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 211 Argentina Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 212 Argentina Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 213 Argentina Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 214 Argentina Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 215 Argentina Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 216 Argentina Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 217 Colombia Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 218 Colombia Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 219 Colombia Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 220 Colombia Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 221 Colombia Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 222 Colombia Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 223 Colombia Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 224 Chile Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 225 Chile Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 226 Chile Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 227 Chile Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 228 Chile Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 229 Chile Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 230 Chile Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 231 Middle East & Africa Regulatory Affairs, by Country, 2018 - 2030 (USD Billion)
Table 232 Middle East & Africa Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 233 Middle East & Africa Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 234 Middle East & Africa Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 235 Middle East & Africa Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 236 Middle East & Africa Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 237 Middle East & Africa Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 238 Middle East & Africa Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 239 South Africa Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 240 South Africa Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 241 South Africa Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 242 South Africa Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 243 South Africa Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 244 South Africa Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 245 South Africa Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 246 Saudi Arabia Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 247 Saudi Arabia Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 248 Saudi Arabia Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 249 Saudi Arabia Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 250 Saudi Arabia Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 251 Saudi Arabia Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 252 Saudi Arabia Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 253 UAE Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 254 UAE Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 255 UAE Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 256 UAE Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 257 UAE Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 258 UAE Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 259 UAE Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 260 Egypt Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 261 Egypt Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 262 Egypt Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 263 Egypt Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 264 Egypt Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 265 Egypt Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 266 Egypt Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
Table 267 Israel Regulatory Affairs, by Services, 2018 - 2030 (USD Billion)
Table 268 Israel Regulatory Affairs, by Category, 2018 - 2030 (USD Billion)
Table 269 Israel Regulatory Affairs, by Indication, 2018 - 2030 (USD Billion)
Table 270 Israel Regulatory Affairs, by Product Stage, 2018 - 2030 (USD Billion)
Table 271 Israel Regulatory Affairs, by Type, 2018 - 2030 (USD Billion)
Table 272 Israel Regulatory Affairs, by Company Size, 2018 - 2030 (USD Billion)
Table 273 Israel Regulatory Affairs, by End Use, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Regulatory Affairs Market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot 1
Fig. 14 Segment snapshot 2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Regulatory Affairs Market: Services outlook key takeaways
Fig. 20 Regulatory Affairs Market: Services movement analysis
Fig. 21 Regulatory consulting market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Legal representation market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 23 Regulatory writing & publishing market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 24 Writing market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 25 Publishing market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 26 Product registration & clinical trial applications market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 27 Other services market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 28 Regulatory Affairs Market: Category outlook key takeaways
Fig. 29 Regulatory Affairs Market: Category movement analysis
Fig. 30 Drugs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 31 Innovator drugs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 32 Preclinical innovator drugs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 33 Clinical innovator drugs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 34 Pre-Market Approval (PMA) innovator drugs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 35 Generic drugs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 36 Preclinical generic drugs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 37 Clinical generic drugs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 38 Pre-Market Approval (PMA) generic drugs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 39 Biologics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 40 Biotech market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 41 Preclinical biotech market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 42 Clinical biotech market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 43 Pre-Market Approval (PMA) biotech market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 44 ATMP market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 45 Preclinical ATMP market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 46 Clinical ATMP market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 47 Pre-Market Approval (PMA) ATMP market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 48 Biosimilars market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 49 Preclinical biosimilars market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 50 Clinical biosimilars market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 51 Pre-Market Approval (PMA) biosimilars market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 52 Medical Devices market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 53 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 54 Preclinical diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 55 Clinical diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 56 Pre-Market Approval (PMA) diagnostics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 57 Therapeutics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 58 Preclinical therapeutics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 59 Clinical therapeutics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 60 Pre-Market Approval (PMA) therapeutics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 61 Regulatory Affairs Market: Indication outlook key takeaways
Fig. 62 Regulatory Affairs Market: Indication movement analysis
Fig. 63 Oncology market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 64 Neurology market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 65 Cardiology companies market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 66 Immunology market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 67 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 68 Regulatory Affairs Market: Product stage outlook key takeaways
Fig. 69 Regulatory Affairs Market: Product stage movement analysis
Fig. 70 Preclinical market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 71 Clinical studies market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 72 PMA companies market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 73 Immunology market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 74 Regulatory Affairs Market: Type outlook key takeaways
Fig. 75 Regulatory Affairs Market: Type movement analysis
Fig. 76 In-house market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 77 Outsourced market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 78 Regulatory Affairs Market: Company size outlook key takeaways
Fig. 79 Regulatory Affairs Market: Company size movement analysis
Fig. 80 Small market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 81 Medium market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 82 Large market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 83 Regulatory Affairs Market: End Use outlook key takeaways
Fig. 84 Regulatory Affairs Market: End Use movement analysis
Fig. 85 Medical device companies market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 86 Pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 87 Biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 88 Regional marketplace outlook, 2023 & 2030 (USD Billion)
Fig. 89 Regional marketplace: Key takeaways
Fig. 90 North America Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 91 Key country dynamics
Fig. 92 U.S. Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 93 Key country dynamics
Fig. 94 Canada Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 95 Key country dynamics
Fig. 96 Europe Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 97 Key country dynamics
Fig. 98 UK regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 99 Key country dynamics
Fig. 100 Germany Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 101 Key country dynamics
Fig. 102 France Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 103 Key country dynamics
Fig. 104 Spain Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 105 Key country dynamics
Fig. 106 Italy Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 107 Key country dynamics
Fig. 108 Denmark Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 109 Key country dynamics
Fig. 110 Norway Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 111 Key country dynamics
Fig. 112 Netherlands Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 113 Key country dynamics
Fig. 114 Switzerland Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 115 Key country dynamics
Fig. 116 Sweden Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 117 Asia Pacific Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 118 Key country dynamics
Fig. 119 Japan Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 120 Key country dynamics
Fig. 121 China Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 122 Key country dynamics
Fig. 123 India Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 124 Key country dynamics
Fig. 125 Australia Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 126 Key country dynamics
Fig. 127 South Korea Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 128 Key country dynamics
Fig. 129 Thailand Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 130 Latin America Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 131 Key country dynamics
Fig. 132 Brazil Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 133 Key country dynamics
Fig. 134 Mexico Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 135 Key country dynamics
Fig. 136 Argentina Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 137 Key country dynamics
Fig. 138 Colombia regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 139 Key country dynamics
Fig. 140 Chile regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Billion) Key country dynamics
Fig. 141 MEA Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 142 Key country dynamics
Fig. 143 South Africa Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 144 Key country dynamics
Fig. 145 Saudi Arabia Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 146 Key country dynamics
Fig. 147 UAE Regulatory Affairs Market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 148 Key country dynamics
Fig. 149 Egypt regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 150 Key country dynamics
Fig. 151 Israel regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 152 Market participant categorization
Fig. 153 Regulatory affairs market position analysis, 2023
Fig. 154 Strategic framework

Companies Mentioned

  • Accell Clinical Research, LLC
  • Genpact
  • Criterium, Inc.
  • ICON plc
  • iuvo BioScience, LLC.
  • WuXi AppTec
  • Medpace
  • Charles River Laboratories.
  • Laboratory Corporation of America Holdings
  • Parexel International (MA) Corporation
  • Freyr
  • AmerisourceBergen
  • NDA Group AB
  • Pharmexon
  • Qvigilance
  • BlueReg
  • Cambridge Regulatory Services
  • VCLS

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedAugust 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 15 Billion
Forecasted Market Value ( USD ) by 2030 $ 26 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software, Services), By Technology (AI/ML, Big Data Analytics, IoT, Blockchain Technology), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software, Services), By Technology (AI/ML, Big Data Analytics, IoT, Blockchain Technology), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Medical Foods Market Size, Share & Trends Analysis Report by Route of Administration, Product (Powder, Pills, Liquid, Other), Application, Sales Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Medical Foods Market Size, Share & Trends Analysis Report by Route of Administration, Product (Powder, Pills, Liquid, Other), Application, Sales Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Specialty Drug Distribution Market by Disease Indication, Distributor Type, Distribution Type, End-User - Global Forecast 2025-2030 - Product Image

Specialty Drug Distribution Market by Disease Indication, Distributor Type, Distribution Type, End-User - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Pruritus Therapeutics Market by Therapy, Disease Indication, Distribution Channel, Route of Administration - Global Forecast 2025-2030 - Product Image

Pruritus Therapeutics Market by Therapy, Disease Indication, Distribution Channel, Route of Administration - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, Obesity, Fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030 - Product Image

Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, Obesity, Fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030

  • Report
  • 243 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.